Sylvia Cheung | CFO |
Joseph Darling | President & CEO |
Jim Sidoti | Sidoti & Company |
Joe Munda | First Analysis |
Brian Gagnon | Gagnon Securities |
Good evening, ladies and gentlemen, and welcome to Anika Therapeutics Third Quarter 2019 Earnings Conference Call. [Operator Instructions] I will now turn the call over to Sylvia Cheung, Chief Financial Officer. Please proceed.
Thank you, Andrew. Good evening, everyone, and thank you for joining us.